Institute for Diabetes Research and Metabolic Diseases (IDM)

The primary research objective of the Institute for Diabetes Research and Metabolic Diseases (IDM) is diabetes prevention and its personalized therapy

The IDM has access to data from well-phenotyped cohort and multicenter studies involving people with an increased risk of diabetes. Organ crosstalk—the interaction and role of the brain, liver and pancreas in the development of prediabetes and diabetes—is of particular interest. To this end, basic scientists cooperate closely with clinical researchers.

Participating Research Groups and PIs

Translational Diabetology 

  • Prof. Dr. Andreas Birkenfeld, Prof. Dr. Reiner Jumpertz-von Schwartzenberg 

Prevention of Type 2 Diabetes 

  • Prof. Dr. Andreas Fritsche 

Gestational Diabetes

  • Dr. Julia Sbierski-Kind (Junior Research Group) 

Pathophysiology of Prediabetes 

  • Prof. Dr. Norbert Stefan, Prof. Dr. Dr. Fritz Schick 

Pathophysiology of Nephrotic Syndrome 

  • Adjunct Prof. Dr. Ferruh Artunc 

Molecular Diabetology and Exercise

  • Prof. Dr. Cora Weigert, Prof. Dr. Andreas Peter 

Metabolic Neuroimaging

  • Prof. Dr. Hubert Preißl, Dr. Stephanie Kullmann 

Pancreatic Beta Cell Function

  • PD Dr. Felicia Gerst 

Molecular Cell Biology

  • Dr. Gencer Sancar (Junior Research Group)

Participating in DZD Main Research Topics (Academies)

Protection and Regeneration of Beta Cells

Read more

Insulin Action and Resistance in the Brain

Read more

Prevention of Type 2 Diabetes

Read more

Complications of Diabetes

Read more

Causes and Treatment of Non-alcoholic Fatty Liver Disease (NAFLD)

Read more

Speaker and Member of the DZD Executive Board

Prof. Dr. Andreas Birkenfeld
Prof. Dr. Andreas Birkenfeld

Medical Director of the Department of Internal Medicine IV at the University of Tübingen

Scientific Director of the IDM